Lawesson's reagent → HCID 58576480, compound
Reaction equation
[F:1][C:2]([F:36])([F:35])[C:3]1[CH:8]=[CH:7][C:6]([N:9]2[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][CH2:17][C:18]([N:20]3[CH2:25][CH2:24][CH:23]([NH:26][C:27]4[CH:34]=[CH:33][C:30]([C:31]#[N:32])=[CH:29][CH:28]=4)[CH2:22][CH2:21]3)=O)[CH2:11][CH2:10]2)=[CH:5][CH:4]=1.COC1C=CC(P2(SP(C3C=CC(OC)=CC=3)(=S)S2)=[S:46])=CC=1>>[F:1][C:2]([F:36])([F:35])[C:3]1[CH:8]=[CH:7][C:6]([N:9]2[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][CH2:17][C:18]([N:20]3[CH2:25][CH2:24][CH:23]([NH:26][C:27]4[CH:34]=[CH:33][C:30]([C:31]#[N:32])=[CH:29][CH:28]=4)[CH2:22][CH2:21]3)=[S:46])[CH2:11][CH2:10]2)=[CH:5][CH:4]=1Participants
3
Conditions
- Temperature
- 102.5 °C
Procedure
4-(1-{4-[4-(4-Trifluoromethyl-phenyl)-piperazin-1-yl]-butyryl}-piperidin-4-ylamino)-benzonitrile (7 mg; 0.014 mmol, prepared in accordance with Example 83) is reacted with Lawesson's reagent (3 mg; 0.007 mmol) and the resulting mixture is heated between at 95 to 110° C. for 2 hours. In cases where incomplete conversion of the starting amide is observed, additional portion of Lawesson's reagent is added and the mixture heated further until no evolution of the conversion is observed. The reaction mixture is concentrated under reduced pressure and the crude residue is purified by preparative HPLC (1 mg; 0.002 mmol). The structure was confirmed using Protocol I-B. Calculated mass=516; observed mass=516; HPLC retention time=4.53 min.
Workup
- temperaturethe mixture heated further until no evolution of the conversion
- concentrationThe reaction mixture is concentrated under reduced pressure
- customthe crude residue is purified by preparative HPLC (1 mg; 0.002 mmol)
Sources & evidence
- ORD record
- ord-9489e99577214ffa8ed6424fc1e16fd8
- Source dataset
- uspto-grants-2015_08
- Patent number
- US09096524B2
Reaction notes
Loading…